PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 143 filers reported holding PLIANT THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.42 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,010,376 | -4.3% | 288,949 | 0.0% | 0.53% | -37.0% |
Q2 2023 | $5,235,756 | -86.2% | 288,949 | -79.8% | 0.84% | -88.7% |
Q1 2023 | $38,038,000 | +82.2% | 1,430,000 | +32.4% | 7.43% | +111.2% |
Q4 2022 | $20,876,400 | -7.5% | 1,080,000 | 0.0% | 3.52% | +1.0% |
Q3 2022 | $22,561,000 | – | 1,080,000 | – | 3.48% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 5,839,160 | $98,565,000 | 18.71% |
CHI Advisors LLC | 2,484,724 | $41,942,000 | 12.24% |
TRV GP IV, LLC | 2,132,867 | $36,003,000 | 8.17% |
Bond & Devick Financial Network, Inc. | 120,160 | $2,028,000 | 1.68% |
Fernwood Investment Management, LLC | 166,447 | $2,810,000 | 0.96% |
Redmile Group, LLC | 3,083,501 | $52,049,000 | 0.91% |
HARVARD MANAGEMENT CO INC | 562,379 | $9,493,000 | 0.56% |
Grace Capital | 48,058 | $808,000 | 0.50% |
Eventide Asset Management | 2,183,238 | $36,853,000 | 0.49% |
Cormorant Asset Management, LP | 482,413 | $8,143,000 | 0.33% |